Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2014
10/30/2014US20140322224 Monoclonal antibodies against serotransferrin antigens, and uses therefor
10/30/2014US20140322223 Tox3 as a biomarker for breast cancer
10/30/2014US20140322222 Compounds and methods for the modulation of beta-1 integrin function to mediate tissue repair
10/30/2014US20140322221 Multivalent antibodies and uses therefor
10/30/2014US20140322220 Anti-FGFR2 Antibodies and Uses Thereof
10/30/2014US20140322219 Anti-factor xi monoclonal antibodies and methods of use thereof
10/30/2014US20140322218 Antibody Constructs for CDH19 and CD3
10/30/2014US20140322217 Novel heterodimeric proteins
10/30/2014US20140322216 Glypican-3-specific antibody and uses thereof
10/30/2014US20140322215 Methods of inhibiting tumor growth by antagonizing il-6 receptor
10/30/2014US20140322214 Therapeutic applications of activation of human antigen-presenting cells through dectin-1
10/30/2014US20140322212 Effective targeting of primary human leukemia using anti-cd123 chimeric antigen receptor engineered t cells
10/30/2014US20140322211 Tenascin-c and use thereof in rheumatoid arthritis
10/30/2014US20140322210 Antibodies useful in passive influenza immunization
10/30/2014US20140322209 Administration of alpha4beta7 hetero- dimer-specific antibody
10/30/2014US20140322208 Treatment of hematologic malignancies with an anti-cxcr4 antibody
10/30/2014US20140322206 Method for treating atrophic age related macular degeneration
10/30/2014US20140322204 Treatment and prevention of viral infections
10/30/2014US20140322203 Formulations with reduced oxidation
10/30/2014US20140322202 TREATMENT WITH ANTI ErbB2 ANTIBODIES
10/30/2014US20140322201 Methods of treating multiple myeloma using combination therapies based on anti-cs1 antibodies
10/30/2014US20140322199 Methods of treating cardiovascular and metabolic diseases
10/30/2014US20140322183 Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
10/30/2014US20140322163 Neutralizing antibodies to hiv-1 and their use
10/30/2014US20140322161 Anti-il-6 vaccine composition
10/30/2014US20140322160 Method and composition for altering a b cell mediated pathology
10/30/2014US20140322134 Treatment and Imaging Methods Using Antibodies to Aminophospholipids
10/30/2014US20140322132 Fragments of p97 and uses thereof
10/30/2014US20140322131 Methods and Agents for the Diagnosis and Treatment of Hepatocellular Carcinoma
10/30/2014US20140322130 Specific binding proteins and uses thereof
10/30/2014US20140322129 Anti-b7-h4 antibodies and immunoconjugates
10/28/2014US8871914 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
10/28/2014US8871913 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
10/28/2014US8871912 Engineered heterodimeric protein domains
10/28/2014US8871911 Compositions and methods for the diagnosis and treatment of tumor
10/28/2014US8871910 Antibodies inhibiting c-Met dimerization, and uses thereof
10/28/2014US8871909 Antibodies inhibiting c-Met dimerization and uses thereof
10/28/2014US8871908 Antibodies specific for Trop-2 and their uses
10/28/2014US8871907 Glycosylated immunoglobulin and immunoadhesin comprising the same
10/28/2014US8871709 Synthetic chimeric proteins comprising epidermal growth factor and vitronectin
10/28/2014US8871518 Monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same
10/28/2014US8871490 Alpha-4-beta-7 heterodimer specific antagonist antibody
10/28/2014US8871467 Polynucleotides encoding antibodies that bind both IL-17A and IL-17F
10/28/2014US8871455 Biomarker panels for assessing radiation injury and exposure
10/28/2014US8871452 Methods for treatment of cardiovascular disease
10/28/2014US8871449 Methods and products for evaluating an immune response to a therapeutic protein
10/28/2014US8871447 Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence
10/28/2014US8871216 Multiple signaling pathways induced by hexvalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases
10/28/2014US8871213 Prevention, treatment and diagnosis of P. gingivalis infection
10/28/2014US8871209 Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or Activin A
10/28/2014US8871207 Neutralizing anti-influenza A virus antibodies and uses thereof
10/28/2014US8871206 Anti-human folate receptor beta antibodies and methods of use
10/28/2014US8871205 Methods and compositions for the treatment of immune disorders
10/28/2014US8871204 Active protease-resistant antibody FC mutants
10/28/2014US8871203 Method of treating a pathological syndrome and a pharmaceutical agent
10/28/2014US8871202 Prevention and treatment of pain using antibodies to sphingosine-1-phosphate
10/28/2014US8871201 Stabilizing formulations
10/28/2014US8871192 IL-1F8 polypeptides
10/23/2014US20140317778 Nucleic acid molecules encoding enzymes that confer disease resistance in jute
10/23/2014US20140317765 Transgenic birds that produce chimeric human immunoglobulins
10/23/2014US20140316186 Antibodies to tip-1 and grp78
10/23/2014US20140316115 Method of antibody purification
10/23/2014US20140316113 Method for the humanization of antibodies and humanized antibodies thereby obtained
10/23/2014US20140315817 Variant serum albumin with improved half-life and other properties
10/23/2014US20140315746 Compositions and methods for the treatment of prostate carcinoma
10/23/2014US20140315252 Cd40l expressing mammalian cells and their use
10/23/2014US20140315251 Interleukin-31 Monoclonal Antibody
10/23/2014US20140315250 Humanized antibodies against tl1a
10/23/2014US20140315249 Inducible eukaryotic expression system
10/23/2014US20140315215 Thermostable assay reagents
10/23/2014US20140314864 System for Targeted Delivery of Therapeutic Agents
10/23/2014US20140314837 Vaccine Therapy
10/23/2014US20140314836 Modulation of Midbody Derivatives
10/23/2014US20140314832 Lung-targeting nanobodies against pulmonary surfactant protein a and their preparation
10/23/2014US20140314830 Bacterially formed microcin s, a new antimicrobial peptide, effective against pathogenic microorganisms, e.g. enterohemorrhagic escherichia coli (ehec)
10/23/2014US20140314796 Marker for neuromyelitis optica
10/23/2014US20140314793 Biological materials and uses thereof
10/23/2014US20140314792 Method for the diagnosis, prognosis and treatment of cancer metastasis
10/23/2014US20140314791 Methods of treating cancer
10/23/2014US20140314790 Caspase 9 inhibition and bri2 peptides for treating dementia
10/23/2014US20140314789 CaMKII, IP3R, CALCINEURIN, P38 AND MK2/3 INHIBITORS TO TREAT METABOLIC DISTURBANCES OF OBESITY
10/23/2014US20140314788 Modulation of histone deacetylases for the treatment of metabolic disease, methods and compositions related thereto
10/23/2014US20140314787 Treatment for neurodegenerative diseases
10/23/2014US20140314784 Anti-cxcr4 antibodies and methods of use
10/23/2014US20140314783 Methods for suppressing allergic reactions
10/23/2014US20140314782 Anti-notch2 nrr antibodies
10/23/2014US20140314781 Formulation of human antibodies for treating tnf-alpha associated disorders
10/23/2014US20140314779 Cell culture compositions with antioxidants and methods for polypeptide production
10/23/2014US20140314777 Monoclonal antibodies targeting neutralizing epitopes on h5 influenza virus of clade 2.3
10/23/2014US20140314776 Method of treating alveolar bone loss through the use of anti-sclerostin antibodies
10/23/2014US20140314775 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment of anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease
10/23/2014US20140314774 Her3 antibodies and uses thereof
10/23/2014US20140314773 Compositions and methods for treating alzheimer's disease
10/23/2014US20140314772 Anti-c5a binding moieties with high blocking activity
10/23/2014US20140314770 Kidney disease targets and uses thereof
10/23/2014US20140314769 Neutralizing Antibodies And Methods Of Use Thereof
10/23/2014US20140314768 Methods and compositions for treating and diagnosing diseases
10/23/2014US20140314767 Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide
10/23/2014US20140314766 Mig-7 as a specific anticancer target
10/23/2014US20140314764 Bi-specific antibodies for medical use
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 1494